CSPC Innovation (China) Today

300765 Stock   27.45  0.31  1.14%   

Performance

5 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 9

 
High
 
Low
Low
CSPC Innovation is trading at 27.45 as of the 27th of November 2024, a 1.14% up since the beginning of the trading day. The stock's open price was 27.14. CSPC Innovation has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for CSPC Innovation Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Business Domain
Food, Beverage & Tobacco
Category
Consumer Defensive
Classification
Consumer Staples
CSPC Innovation is entity of China. It is traded as Stock on SHE exchange. The company has 1.4 B outstanding shares. More on CSPC Innovation Pharmaceutical

Moving together with CSPC Stock

  0.8601658 Postal Savings BankPairCorr

CSPC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CSPC Innovation's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CSPC Innovation or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationPackaged Foods & Meats, Food, Beverage & Tobacco, Consumer Defensive, Consumer Staples, Food Products, Packaged Foods, Consumer Defensive (View all Sectors)
CSPC Innovation's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CSPC Innovation's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
CSPC Innovation can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CSPC Innovation's financial leverage. It provides some insight into what part of CSPC Innovation's total assets is financed by creditors.
Liquidity
CSPC Innovation cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. CSPC Innovation Pharmaceutical has accumulated 544.96 M in total debt. Debt can assist CSPC Innovation until it has trouble settling it off, either with new capital or with free cash flow. So, CSPC Innovation's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CSPC Innovation Phar sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CSPC to invest in growth at high rates of return. When we think about CSPC Innovation's use of debt, we should always consider it together with cash and equity.

Change To Inventory

4.1 Million
CSPC Innovation Pharmaceutical (300765) is traded on Shenzhen Stock Exchange in China and employs 1,887 people. CSPC Innovation is listed under Packaged Foods & Meats category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 39.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSPC Innovation's market, we take the total number of its shares issued and multiply it by CSPC Innovation's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CSPC Innovation Phar operates under Food Products sector and is part of Consumer Staples industry. The entity has 1.4 B outstanding shares. CSPC Innovation generates positive cash flow from operations, but has no cash available
Check CSPC Innovation Probability Of Bankruptcy
Ownership Allocation
CSPC Innovation holds a total of 1.4 Billion outstanding shares. CSPC Innovation Pharmaceutical shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.26 percent of CSPC Innovation Phar outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CSPC Ownership Details

CSPC Innovation Phar Risk Profiles

Although CSPC Innovation's alpha and beta are two of the key measurements used to evaluate CSPC Innovation's performance over the market, the standard measures of volatility play an important role as well.

CSPC Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in CSPC Innovation without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

CSPC Innovation Corporate Executives

Elected by the shareholders, the CSPC Innovation's board of directors comprises two types of representatives: CSPC Innovation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSPC. The board's role is to monitor CSPC Innovation's management team and ensure that shareholders' interests are well served. CSPC Innovation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSPC Innovation's outside directors are responsible for providing unbiased perspectives on the board's policies.
Long DaiSecretary CFOProfile

Other Information on Investing in CSPC Stock

CSPC Innovation financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Innovation security.